NCT00002946View on ClinicalTrials.gov

Penclomedine in Treating Patients With Solid Tumors or Lymphoma

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 31, 1997

Primary Completion Date

April 30, 2002

Conditions
LymphomaUnspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

penclomedine

Trial Locations (1)

53792

University of Wisconsin Comprehensive Cancer Center, Madison

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00002946 - Penclomedine in Treating Patients With Solid Tumors or Lymphoma | Biotech Hunter | Biotech Hunter